Zobrazeno 1 - 10
of 122
pro vyhledávání: '"Philip Schoenfeld"'
Publikováno v:
Gastroenterology Research and Practice, Vol 2018 (2018)
Goal. To prospectively assess physician recommendations for repeat colonoscopy in an average-risk screening cohort. Background. Endoscopists’ adherence to colorectal cancer screening and surveillance guidelines for repeat colonoscopy have not been
Externí odkaz:
https://doaj.org/article/14fb6042e0604b6fb518fe7cd4a94a3b
Autor:
Neehar D. Parikh, Shail M. Govani, Philip Schoenfeld, Alison E. Freeman, Swati G. Patel, Jennifer K. Maratt, Lisa M. Glass, Stacy B. Menees, Anoop Prabhu, Sameer D. Saini, Grace L. Su, Andrew W. Tai, Akbar K. Waljee, Duyen T. Dang, Joel H. Rubenstein
Publikováno v:
GastroHep. 3:254-260
Autor:
Philip Schoenfeld
Publikováno v:
Gastrointestinal Endoscopy Clinics of North America. 30:541-551
The goal of colorectal cancer (CRC) screening with colonoscopy is to minimize CRC with minimal risk and cost. In order to continuously improve the quality of colonoscopy, different outcomes must be measured. For this topic, the priority indicators to
Publikováno v:
Therapeutic Advances in Gastroenterology
Therapeutic Advances in Gastroenterology, Vol 14 (2021)
Therapeutic Advances in Gastroenterology, Vol 14 (2021)
Background: Eluxadoline, a United States Food and Drug Administration (FDA)-approved treatment for irritable bowel syndrome with diarrhea (IBS-D), underwent a change to its US prescribing information on 21 April 2017, contraindicating it in patients
Autor:
Brooks D. Cash, Mei Lu, Emi Terasawa, Brian Terreri, Shawn Du, Rajeev Ayyagari, Paul Feuerstadt, Anthony Lembo, Baha Moshiree, Linda Nguyen, Mena Boules, Philip Schoenfeld
Publikováno v:
American Journal of Gastroenterology. 116:S239-S240
Publikováno v:
Clinical Therapeutics. 44:98-110.e1
Plecanatide, an approved therapy for chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation, is an analogue of uroguanylin that replicates its pH-sensitive activity and binds to guanylate cyclase-C receptors expressed on
Autor:
Hal Morgenstern, Val Metko, Henry D. Appelman, Peter J. Ulintz, Philip Schoenfeld, John M. Inadomi, Anna Tavakkoli, Erika Koeppe, Elena M. Stoffel, Joel H. Rubenstein, James M. Scheiman
Publikováno v:
Clinical and Translational Gastroenterology
INTRODUCTION: We aimed to estimate the effects of a family history of colorectal cancer (CRC) or esophageal cancer on the risk of Barrett's esophagus (BE) and identify variants in cancer genes that may explain the association. METHODS: Men scheduled
Publikováno v:
Gastroenterology Research and Practice, Vol 2018 (2018)
Gastroenterology Research and Practice
Gastroenterology Research and Practice
Goal. To prospectively assess physician recommendations for repeat colonoscopy in an average-risk screening cohort. Background. Endoscopists’ adherence to colorectal cancer screening and surveillance guidelines for repeat colonoscopy have not been
Autor:
Philip Schoenfeld
Publikováno v:
Gastroenterology. 155:1298-1300
Publikováno v:
Digestive Diseases and Sciences
Background Rifaximin has demonstrated efficacy and safety for diarrhea-predominant irritable bowel syndrome (IBS-D). Aim To determine the rifaximin repeat treatment effect on fecal bacterial antibiotic susceptibility. Methods Patients with IBS in Tri